Sirona Biochem Corp.
SRBCF
$0.0418
$0.000.00%
| 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -62.75% | -81.32% | -- | -270.59% | -99.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -62.75% | -81.32% | -- | -270.59% | -99.00% |
| Cost of Revenue | -- | -- | -0.79% | 42.31% | -- |
| Gross Profit | -62.75% | -81.32% | 10.32% | -701.75% | -99.00% |
| SG&A Expenses | -39.85% | 14.44% | 20.57% | -31.10% | -53.16% |
| Depreciation & Amortization | 5.56% | 0.00% | 0.00% | 18.75% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.85% | -49.74% | 12.31% | 51.21% | -57.26% |
| Operating Income | -46.55% | 47.13% | -12.03% | -68.89% | -20.94% |
| Income Before Tax | -63.52% | 45.46% | -17.48% | -70.12% | -33.28% |
| Income Tax Expenses | 380.00% | 68.75% | -33.33% | 33.33% | -266.67% |
| Earnings from Continuing Operations | -64.06% | 45.39% | -17.41% | -70.04% | -33.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -64.06% | 45.39% | -17.41% | -70.04% | -33.02% |
| EBIT | -46.55% | 47.13% | -12.03% | -68.89% | -20.94% |
| EBITDA | -48.88% | 47.30% | -12.08% | -69.28% | -19.38% |
| EPS Basic | -56.25% | 45.45% | -16.67% | -50.00% | -33.33% |
| Normalized Basic EPS | -60.00% | 42.86% | -18.18% | -57.14% | -42.86% |
| EPS Diluted | -56.25% | 45.45% | -16.67% | -50.00% | -33.33% |
| Normalized Diluted EPS | -60.00% | 42.86% | -18.18% | -57.14% | -42.86% |
| Average Basic Shares Outstanding | 2.56% | 1.03% | 0.72% | 6.94% | 0.18% |
| Average Diluted Shares Outstanding | 2.56% | 1.03% | 0.72% | 6.94% | 0.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
